Investor Diligence and Decision Support
We support VC/CVC teams, Private Equity, Hedge Funds, and other investors with decision-grade intelligence in BioPharma, HealthTech, and AI-enabled healthcare. From fast diligence to ongoing monitoring, we help you validate assumptions, surface risks early, and act with confidence.
From identifying emerging trends and hidden risks to supporting diligence and portfolio decisions, we deliver concise, actionable recommendations that create an edge.
Our work commonly includes:
- Landscape + diligence (science, commercial, competitive dynamics)
- Company/asset profile (TAM, segmentation, growth drivers, value proposition)
- Opportunity/risk assessment (red flags, catalysts, scenarios, mitigations)
- Custom research aligned to your thesis and timelines (deal-specific questions, thesis validation, monitoring)
Typical engagement modes:
- Diligence Sprint (5–10 business days)
- Monthly monitoring and brief updates
- Decision workshops and AI-powered wargaming when stakes are high
Don’t forget to check out our Lucid Diligence Briefs, delivering 60-second theses, questions to ask, red flags and catalysts to watch, linked to trending news.
Want to move faster on your next decision? Contact: info@lqventures.com
September 27, 2025
ERS 2025 Preview: Key Respiratory Highlights to Watch
September 26, 2025
Vaccines Weekly Update – September 26th 2025
September 26, 2025
Public Health Weekly News – September 26th 2025
September 26, 2025
Latest Public Health News – Sept 11th to Sept 25
September 26, 2025
Respiratory Today—September 26, 2025
September 25, 2025
Latest Cardiovascular News – Sept 10th to Sept 24th 2025
September 25, 2025
Latest Rare Diseases News – Sept 10th to Sept 24th 2025
September 25, 2025
Cell and Gene Therapy Weekly News – September 25th 2025
September 25, 2025
Rare Diseases Weekly News – September 30th 2025
September 25, 2025
Cardiovascular Weekly News – September 25th 2025
September 24, 2025
Neuroscience Weekly News – September 24th 2025
September 24, 2025